Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Silk Road Medical (Nasdaq: SILK), a medical device company dedicated to stroke risk reduction, will participate in the BofA Securities 2023 Healthcare Conference on May 10, 2023, at 4:20 p.m. PT. Interested individuals can access a live and archived webcast via the company’s website.
The company is known for its innovative approach to treating carotid artery disease through a procedure called TransCarotid Artery Revascularization (TCAR), which combines surgical neuroprotection principles with minimally invasive techniques.
For further inquiries, reach the Investor Contact at investors@silkroadmed.com.
Silk Road Medical, Inc. (Nasdaq: SILK) will release its first quarter 2023 financial results on May 9, 2023, after market close, followed by an audio webcast at 1:30 p.m. PT. The company, based in Sunnyvale, California, specializes in reducing stroke risk through its innovative TransCarotid Artery Revascularization (TCAR) procedure. This method merges surgical neuroprotection with minimally invasive techniques to address carotid artery blockages.
Interested parties can register for the conference call online and join the live or replay webcast to gain insights into the company’s financial performance and future outlook.